Top Markets
Coin of the day
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.

Steminent Biotherapeutics Inc.

7729
Peringkat dalam Saham #18868
Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to... Steminent Biotherapeutics Inc. is a biopharmaceutical company dedicated to pioneering novel cellular therapeutics, with a primary focus on the research and development of innovative stem cell drugs. Their flagship product is Stemchymal, which is recognized for its significant therapeutic benefits and broad range of potential applications. The firm was established on December 18, 2007, and operates from its headquarters in Taipei, Taiwan.
Harga Saham
$2.51
Kapitalisasi Pasar
$183.34M
Perubahan (1 hari)
0.90%
Perubahan (1 tahun)
91.17%
Negara
TW
Perdagangan Steminent Biotherapeutics Inc. (7729)

Kategori

Harga 7729 dengan kapitalisasi pasar B
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
7729
$2.51
Kapitalisasi pasar dari Steminent Biotherapeutics Inc.(7729)
Kapitalisasi Pasar: $183.34M
Per August 2026, Steminent Biotherapeutics Inc. memiliki kapitalisasi pasar sebesar $183.34M. Ini menjadikan Steminent Biotherapeutics Inc. sebagai perusahaan 18868th paling bernilai di dunia menurut data kami. Kapitalisasi pasar adalah nilai total saham beredar dari perusahaan publik dan biasanya digunakan untuk mengukur seberapa besar nilai sebuah perusahaan.
Riwayat kapitalisasi pasar Steminent Biotherapeutics Inc. dari 2024 hingga 2026
7729 dibandingkan dengan 5 teratas stocks paling populer
Harga 7729 Aset B Pasar B Hasil
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$69,464.72 $183.34M
$5.076T +2,768,584.52%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$62,813.39 $183.34M
$4.590T +2,503,479.32%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$56,065.84 $183.34M
$4.097T +2,234,539.61%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$50,158.77 $183.34M
$3.665T +1,999,099.12%
Steminent Biotherapeutics Inc. Steminent Biotherapeutics Inc.
$38,025.17 $183.34M
$2.779T +1,515,484.98%